Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on the development of cellular immunotherapies based on its ...
The Race to Treat Cancer, ArQule Inc. Continues Progress Across all Pipeline Assets
ArQule Inc. (NASDAQ: ARQL) is a biopharmaceutical company engaged in the research and development of targeted therapeutics to treat cancers and rare d...
MEI Pharma, Partnerships, Well-Funded Clinical Programs, and Promising Clinical Data Driving Oncology Research
MEI Pharma (Nasdaq: MEIP) is a San Diego-based oncology drug development company with a pipeline of three clinical-stage drug candidates and a managem...
Netlist Shares Gain After Recent ITC Order, Analysts Review and Financial Results
Netlist, Inc. (NASDAQ: NLST) designs, manufactures, and sells modular memory subsystems for the server, high-performance computing, and communications...
BioPharmX Displays Progress in BPX-01 and BPX-04 Clinicals, Analyst Review and Target
BioPharmX Corporation (NYSE American: BPMX) is a Silicon Valley-based specialty pharmaceutical company, which seeks to provide products through propri...
Office Depot Revises 2018 Outlook, Analyst Review and Target
Office Depot, Inc. (NASDAQ: ODP) is a leading provider of business services and supplies, products and technology solutions through its fully integrat...
Navios Maritime Vessel Upgrades, Reinstated Dividend, Analysts Review and Target
Navios Maritime Partners L.P. (NYSE: NMM) is a publicly traded master limited partnership which owns and operates container and dry bulk vessels. &nbs...
Viking Therapeutics Shares Double on VK2809 Update, Analyst Review and Target
Viking Therapeutics, Inc. (NASDAQ: VKTX) is a clinical-stage biopharmaceutical company focused on the development of novel, therapies for metabolic an...
Green Organic Dutchman Holdings Shares Gain as Canadian Cannabis Legalization Draws Near
Green Organic Dutchman Holdings Ltd. (OTCPK: TGODF) is a research & development company licensed under the Access to Cannabis for Medical Purposes...
Co-Diagnostics Shares Soar on Recent Developments, Technology Profile
Co-Diagnostics, Inc. (NASDAQ: CODX), is a molecular diagnostics company that intends to manufacture and sell reagents used for diagnostic tests that f...